SCNI
Scinai Immunotherapeutics Ltd. American Depositary Shares
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Scinai Immunotherapeutics (SCNI) Stock: Buy, Sell, or Hold?
$0.51
+0.02 (+4.96%)
▲
5d:
+13.41%
30d:
-58.62%
90d:
+112.08%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
60/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.44 – $1.03
Position: SLIGHTLY LOW
Wall Street Target
$700.00
+137424.6% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.39 / $0.56
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SCNI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $0.51, which is considered slightly low relative to its 30-day fair value range of $0.44 to $1.03.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $0.39, while resistance sits at $0.56. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: SCNI scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $700.00 (+137424.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $0.39, while resistance sits at $0.56. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: SCNI scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $700.00 (+137424.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.44 -
$1.03
Company Quality Score
60/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.44 -
$1.03
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.39
Resistance Level
$0.56
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (87/100)
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 137424.6% below Wall St target ($700.00)
- CAUTION: Bottoming setup, but lagging the sector by 32% over 20 days — wait for relative strength
Fundamental Context
Wall Street Target
$700.00
(+137424.6%)
Revenue Growth (YoY)
572.5%
Earnings Growth (YoY)
87.2%
Profit Margin
-80.1%
Share SCNI Analysis
Share this live SCNI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 8:50 PM ET
Data refreshes hourly during market hours. Next update: 9:50 PM
Data refreshes hourly during market hours. Next update: 9:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SCNI Research Pages